PEDIATRICS Vol. 86 No. 1 July 1990, pp. 95-101
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolraich, M. L.
Right arrow Articles by Watson, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolraich, M. L.
Right arrow Articles by Watson, D.

Stimulant Medication Use by Primary Care Physicians in the Treatment of Attention Deficit Hyperactivity Disorder

Mark L. Wolraich MD1, Scott Lindgren PhD1, Ann Stromquist PhD1, Richard Milich PhD1, Charles Davis PhD1, and Doretta Watson 1

1 From the Division of Developmental Disabilities, Department of Pediatrics, and Department of Preventive Medicine, University of Iowa, Iowa City; and Department of Psychology, University of Kentucky, Lexington

Treatment of attention deficit hyperactivity disorder (ADHD), one of the most common behavioral disorders in children in the United States, remains controversial because of concern about stimulant medication use. Extending a previous study of pediatricians, the present study surveyed a random national sample of family practitioners and then directly screened 457 patients of 10 pediatricians and family practitioners in two small midwestern cities. Responses to the national survey indicated that stimulant medication remains the main treatment prescribed by primary care physicians for children with ADHD. In the direct patient screening, the prevalence of ADHD diagnoses was 5.3% (pediatricians) and 4.2% (family practitioners) of all elementary-schoolaged children screened. Eighty-eight percent of these children were treated with methyiphenidate. Although medication was considered an effective treatment by the parents of 85% of the children given the medication, efficacy was unrelated to the accuracy of diagnosis. When explicit DSM-III-R criteria were used, only 72% of those assigned a diagnosis of ADHD by the physicians would have received that diagnosis based on a structured psychiatric interview with the parents and only 53% received that diagnosis based on teacher report of symptoms, even when the child was not receiving medication. Although the majority of physicians (in both the surveys and the direct screenings) reported using at least some behavioral treatments with their patients, parents reported infrequent use of nonpharmacologic forms of therapy, such as behavior modification. These data thus indicate a relatively modest rate of stimulant medication use for ADHD, but a serious underuse of systematic behavioral treatments in primary care.

Key Words: attention deficit hyperactivity disorder • stimulant medication • behavior modification

Submitted on July 3, 1989
Accepted on September 11, 1989




This article has been cited by other articles:


Home page
 Journal of Emotional and Behavioral DisordersHome page
L. K. Leslie, K. M. Lambros, G. A. Aarons, R. A. Haine, and R. L. Hough
School-Based Service Use by Youth With ADHD in Public-Sector Settings
Journal of Emotional and Behavioral Disorders, September 1, 2008; 16(3): 163 - 177.
[Abstract] [PDF]

Home page
 PediatricsHome page
D. A. Christakis
Can We Turn a Toxin Into a Tonic? Toward 21st-Century Television Alchemy
Pediatrics, September 1, 2007; 120(3): 647 - 648.
[Full Text] [PDF]

Home page
 J Pediatr PsycholHome page
L. K. Leslie and M. L. Wolraich
ADHD Service Use Patterns in Youth
J. Pediatr. Psychol., July 1, 2007; 32(6): 695 - 710.
[Abstract] [Full Text] [PDF]

Home page
 J Atten DisordHome page
M. W. Handler and G. J. DuPaul
Assessment of ADHD: Differences Across Psychology Specialty Areas
J Atten Disord, November 1, 2005; 9(2): 402 - 412.
[Abstract] [PDF]

Home page
 J Atten DisordHome page
M. L. Wolraich, L. Bickman, E. W. Lambert, T. Simmons, and M. A. Doffing
Intervening to Improve Communication Between Parents, Teachers, and Primary Care Providers of Children With ADHD or at High Risk for ADHD
J Atten Disord, August 1, 2005; 9(1): 354 - 368.
[Abstract] [PDF]

Home page
 PediatricsHome page
J. S. Palfrey, T. F. Tonniges, M. Green, and J. Richmond
Introduction: Addressing the Millennial Morbidity--The Context of Community Pediatrics
Pediatrics, April 1, 2005; 115(4/S1): 1121 - 1123.
[Full Text] [PDF]

Home page
 PediatricsHome page
L. K. Leslie, J. Weckerly, D. Plemmons, J. Landsverk, and S. Eastman
Implementing the American Academy of Pediatrics Attention-Deficit/Hyperactivity Disorder Diagnostic Guidelines in Primary Care Settings
Pediatrics, July 1, 2004; 114(1): 129 - 140.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
M. Lorberboym, N. Watemberg, A. Nissenkorn, B. Nir, and T. Lerman-Sagie
Technetium 99m Ethylcysteinate Dimer Single-Photon Emission Computed Tomography (SPECT) During Intellectual Stress Test in Children and Adolescents With Pure Versus Comorbid Attention-Deficit Hyperactivity Disorder (ADHD)
J Child Neurol, February 1, 2004; 19(2): 91 - 96.
[Abstract] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
A. Martin and D. Leslie
Trends in Psychotropic Medication Costs for Children and Adolescents, 1997-2000
Arch Pediatr Adolesc Med, October 1, 2003; 157(10): 997 - 1004.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
E. R. Cox, B. R. Motheral, R. R. Henderson, and D. Mager
Geographic Variation in the Prevalence of Stimulant Medication Use Among Children 5 to 14 Years Old: Results From a Commercially Insured US Sample
Pediatrics, February 1, 2003; 111(2): 237 - 243.
[Abstract] [Full Text] [PDF]

Home page
 Psychiatr. Serv.Home page
A. Martin, T. Van Hoof, D. Stubbe, T. Sherwin, and L. Scahill
Multiple Psychotropic Pharmacotherapy Among Child and Adolescent Enrollees in Connecticut Medicaid Managed Care
Psychiatr Serv, January 1, 2003; 54(1): 72 - 77.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
D. A. Kube, M. C. Petersen, and F. B. Palmer
Attention Deficit Hyperactivity Disorder: Comorbidity and Medication Use
Clinical Pediatrics, September 1, 2002; 41(7): 461 - 469.
[Abstract] [PDF]

Home page
 Psychiatr. Serv.Home page
R. Goodwin, M. S. Gould, C. Blanco, and M. Olfson
Prescription of Psychotropic Medications to Youths in Office-Based Practice
Psychiatr Serv, August 1, 2001; 52(8): 1081 - 1087.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. Guevara, P. Lozano, T. Wickizer, L. Mell, and H. Gephart
Utilization and Cost of Health Care Services for Children With Attention-Deficit/Hyperactivity Disorder
Pediatrics, July 1, 2001; 108(1): 71 - 78.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
W. Gardner, K. J. Kelleher, R. Wasserman, G. Childs, P. Nutting, H. Lillienfeld, and K. Pajer
Primary Care Treatment of Pediatric Psychosocial Problems: A Study From Pediatric Research in Office Settings and Ambulatory Sentinel Practice Network
Pediatrics, October 1, 2000; 106(4): 44e - 44.
[Abstract] [Full Text]

Home page
 PediatricsHome page
Committee on Quality Improvement, Subcommittee on
Clinical Practice Guideline: Diagnosis and Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder
Pediatrics, May 1, 2000; 105(5): 1158 - 1170.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
M. L. Wolraich
The Difference Between Efficacy and Effectiveness Research in Studying Attention-Deficit/Hyperactivity Disorder
Arch Pediatr Adolesc Med, December 1, 1999; 153(12): 1220 - 1221.
[Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
D. L. Wodrich and S. Landau
School Psychologists: Strategic Allies in the Contemporary Practice of Primary Care Pediatrics
Clinical Pediatrics, October 1, 1999; 38(10): 597 - 606.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
L. M. Robison, D. A. Sclar, T. L. Skaer, and R. S. Galin
National Trends in the Prevalence of Attention-Deficit/Hyperactivity Disorder and the Prescribing of Methylphenidate among School-Age Children: 1990-1995
Clinical Pediatrics, May 1, 1999; 38(4): 209 - 217.
[Abstract] [PDF]

Home page
 J Atten DisordHome page
M. T. Sloan, P. Jensen, and L. Kettle
Assessing the services for children with ADHD: Gaps and opportunities
J Atten Disord, April 1, 1999; 3(1): 13 - 29.
[Abstract] [PDF]

Home page
 PediatricsHome page
R. C. Wasserman, K. J. Kelleher, A. Bocian, A. Baker, G. E. Childs, F. Indacochea, C. Stulp, and W. P. Gardner
Identification of Attentional and Hyperactivity Problems in Primary Care: A Report From Pediatric Research in Office Settings and the Ambulatory Sentinel Practice Network
Pediatrics, March 1, 1999; 103(3): 38e - 38.
[Abstract] [Full Text]

Home page
 JAMAHome page
L. S. Goldman, M. Genel, R. J. Bezman, P. J. Slanetz, and for the Council on Scientific Affairs, American Me
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
JAMA, April 8, 1998; 279(14): 1100 - 1107.
[Abstract] [Full Text] [PDF]

Home page
 Psychiatr. Serv.Home page
D. A. Zarin, T. L. Tanielian, A. P. Suarez, and S. C. Marcus
Datapoints: Treatment of Attention-Deficit Hyperactivity Disorder by Different Physician Specialties
Psychiatr Serv, February 1, 1998; 49(2): 171 - 171.
[Full Text]

Home page
 CLIN PEDIATRHome page
D. A. Kube and B. K. Shapiro
Persistent School Dysfunction: Unrecognized Comorbidity and Suboptimal Therapy
Clinical Pediatrics, November 1, 1996; 35(11): 571 - 576.
[Abstract] [PDF]

Home page
 J Atten DisordHome page
D.A. Granger, C.K. Whalen, B. Henker, C. Cantwell, D. A. Granger, C. K. Whalen, B. Henker, and C. Cantwell
ADHD boys' behavior during structured classroom social activities: Effects of social demands, teacher proximity, and methylphenidate
J Atten Disord, April 1, 1996; 1(1): 16 - 30.
[Abstract]

Home page
 CLIN PEDIATRHome page
R. D. Waldrop
Selection of Patients for Management of Attention Deficit Hyperactivity Disorder in a Private Practice Setting
Clinical Pediatrics, February 1, 1994; 33(2): 83 - 87.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
J. DiTraglia
Methylphenidate Protocol: Feasibility in a Pediatric Practice
Clinical Pediatrics, December 1, 1991; 30(12): 656 - 660.
[Abstract] [PDF]